LeMaitre Vascular Inc
NASDAQ:LMAT
LeMaitre Vascular Inc
Long-Term Debt
LeMaitre Vascular Inc
Long-Term Debt Peer Comparison
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Long-Term Debt
$16B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Long-Term Debt
$9.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Long-Term Debt
$10.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
17%
|
|
Abbott Laboratories
NYSE:ABT
|
Long-Term Debt
$12.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
14%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LeMaitre Vascular Inc's Long-Term Debt?
Long-Term Debt
0
USD
Based on the financial report for Mar 31, 2024, LeMaitre Vascular Inc's Long-Term Debt amounts to 0 USD.